Tarveda Therapeutics is discovering and developing a new class of potent and selective precision oncology medicines for the treatment of patients with various solid tumor malignancies. Our strategy includes developing our own proprietary Pentarin miniature conjugates to enhance the effectiveness of promising anti-cancer payloads that have struggled without their selective targeting to solid tumors.
Tarveda Therapeutics is building a team to discover and develop transformational medicines that truly impact the lives of cancer patients. Our Pentarin miniature conjugates, which are now in human clinical trials, allow the targeting of very promising anti-cancer payloads to solid tumor malignancies while reducing the impact on healthy tissue.
Improving the lives of patients battling cancer is our GOAL, with the ultimate potential for curing patients of specific cancers. Significantly raising the standard of care is our starting point. We are applying our novel technologies to make advances beyond today’s cancer treatments to benefit patients and their families.
We are looking for high-energy, talented people to join our diverse team and who thrive in innovative, entrepreneurial environments. Our culture is patient-focused, collaborative, and team-based to foster innovation in a setting where ideas are rapidly expanded into breakthroughs.